NCT00151749 WelChol® and Insulin in Treating Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00147758 WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00147745 Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00147719 WelChol® With Metformin in Treating Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00145574 Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol Status COMPLETED Phase PHASE4
NCT00143520 Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes Status COMPLETED Phase PHASE2/PHASE3
NCT00122447 Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance Status COMPLETED Phase NA
NCT00107900 Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement Status COMPLETED Phase PHASE2
NCT00098137 Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT00097591 A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention Status COMPLETED Phase PHASE3
NCT00080834 DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00077077 DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00064220 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT00061854 Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00055952 Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor Status COMPLETED Phase PHASE2
NCT00055939 Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma Status COMPLETED Phase PHASE2
NCT00023972 Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00017511 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00017212 DX-8951f in Treating Patients With Metastatic Stomach Cancer Status COMPLETED Phase PHASE2